Jeffrey W Sherman sold $334K of Xeris Biopharma (XERS)

Executed Aug 28 2025, disclosed Aug 29 2025, 1 day later.

Value, as filed

$334K

42,232 sh × $7.92

Executed

Aug 28 2025

the trade date, as filed

Disclosed

Aug 29 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JS Jeffrey W Sherman Director profile →

Jeffrey W Sherman (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Xeris Biopharma Holdings, Inc. (XERS). The largest single filing was $334K of XERS (42,232 sh × $7.92, as filed), executed Aug 28 2025.

The name

XERS Xeris Biopharma Holdings, Inc. XERS · Healthcare · 26 filings in 24 months ticker →

Healthcare · Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chron…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→